India
· Delayed Price · Currency is INR Biocon Company Description
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally.
It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab.
It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies.
Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
| Country | India |
| Founded | 1978 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 16,315 |
| CEO | Siddharth Mittal |
Contact Details
Address: 20th KM Hosur Road Bengaluru, Karnataka 560100 India | |
| Phone | 91 80 2808 2808 |
| Website | biocon.com |
Stock Details
| Ticker Symbol | 532523 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Siddharth Mittal | Chief Executive Officer |
| Mukesh Kamath | Chief Financial Officer |
| Arun Gupta | Chief Operating Officer |
| Saurabh Paliwal | Head of Investor Relations |